title: Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration.
authors.affiliation: Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
authors.forename: B
authors.initials: B
authors.lastname: Mets
authors.forename: R E
authors.initials: RE
authors.lastname: Michler
authors.forename: E D
authors.initials: ED
authors.lastname: Delphin
authors.forename: M C
authors.initials: MC
authors.lastname: Oz
authors.forename: D W
authors.initials: DW
authors.lastname: Landry
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000638:Amiodarone / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001794:Blood Pressure; D002315:Cardiopulmonary Bypass / Q000379:methods*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D016027:Heart Transplantation; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects*; D014667:Vasopressins / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D014665:Vasodilator Agents; D014667:Vasopressins; D000638:Amiodarone